BRAZILIAN IBD STUDY GROUP POSITION STATEMENT ON SARS-COV2 VACCINATION
Jan-Mar;
Non-conventional
in English
| Jan-Mar | ID: covidwho-1206219
ABSTRACT
Mass vaccination offers the best strategy to fight against COVID-19 pandemic, and SARS-CoV2 vaccines are being approved in several countries for emergency use. In Brazil, vaccine approval is expected in the next few days, however potential concerns exist regarding vaccine recommendations for specific populations, such as patients with inflammatory bowel disease (IBD). To address these questions, the Brazilian IBD Study Group (GEDIIB) provides this practical advice with key recommendations about the COVID-19 vaccines in IBD population.
Full text:
Available
Collection:
Databases of international organizations
Database:
Jan-Mar
Topics:
Vaccines
Country/Region as subject:
South America
/
Brazil
Language:
English
Document Type:
Non-conventional
Similar
MEDLINE
...
LILACS
LIS